Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies

Osama AA Ahmed,1,2 Khalid M El-Say,1,3 Bader M Aljaeid,1 Shaimaa M Badr-Eldin,1,4 Tarek A Ahmed1,3 1Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Minia Universi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ahmed OAA, El-Say KM, Aljaeid BM, Badr-Eldin SM, Ahmed TA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/927ac8e92e704923aadabbfecaf394fa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:927ac8e92e704923aadabbfecaf394fa
record_format dspace
spelling oai:doaj.org-article:927ac8e92e704923aadabbfecaf394fa2021-12-02T07:31:18ZOptimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies1178-2013https://doaj.org/article/927ac8e92e704923aadabbfecaf394fa2018-12-01T00:00:00Zhttps://www.dovepress.com/optimized-vinpocetine-loaded-vitamin-e-d-alpha-tocopherol-polyethylene-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Osama AA Ahmed,1,2 Khalid M El-Say,1,3 Bader M Aljaeid,1 Shaimaa M Badr-Eldin,1,4 Tarek A Ahmed1,3 1Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Minia University, Minia, Egypt; 3Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt; 4Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt Background: Vinpocetine (VNP), a semisynthetic natural product, is used as a vasodilator for cerebrovascular and age-related memory disorders. VNP suffers from low oral bioavailability owing to its low water solubility and extensive first-pass metabolism. This work aimed at utilizing D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) and alpha lipoic acid (ALA) to develop efficient micellar system for transdermal delivery of VNP. Materials and methods: VNP-TPGS-ALA micelles were prepared, characterized for particle size using particle size analyzer, and investigated for structure using transmission electron microscope. Optimization of VNP-TPGS-ALA micelles-loaded transdermal films was performed using Box–Behnken experimental design. The investigated factors were percentage of ALA in TPGS (X1), citral concentration (X2), and propylene glycol concentration (X3). Elongation percent (Y1), initial permeation after 2 hours (Y2), and cumulative permeation after 24 hours (Y3) were studied as responses. Results: Statistical analysis revealed optimum levels of 16.62%, 3%, and 2.18% for X1, X2, and X3, respectively. Fluorescent laser microscopic visualization of skin penetration of the optimized transdermal film revealed marked widespread fluorescence intensity in skin tissue after 0.5, 2, and 4 hours compared with raw VNP transdermal film formulation, which indicated enhancement of VNP skin penetration. Conclusion: The obtained results highlighted the potentiality of VNP nanostructure-based films for controlling the transdermal permeation of the drug and improving its effectiveness. Keywords: bioavailability, box behnken design, citral, fluorescent laser microscope, nanostructured-based films, permeationAhmed OAAEl-Say KMAljaeid BMBadr-Eldin SMAhmed TADove Medical PressarticleAlpha lipoic acidBioavailabilityBox Behnken designD-α-Tocopherol polyethylene glycol succinateOptimizationTransdermal filmsMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 33-43 (2018)
institution DOAJ
collection DOAJ
language EN
topic Alpha lipoic acid
Bioavailability
Box Behnken design
D-α-Tocopherol polyethylene glycol succinate
Optimization
Transdermal films
Medicine (General)
R5-920
spellingShingle Alpha lipoic acid
Bioavailability
Box Behnken design
D-α-Tocopherol polyethylene glycol succinate
Optimization
Transdermal films
Medicine (General)
R5-920
Ahmed OAA
El-Say KM
Aljaeid BM
Badr-Eldin SM
Ahmed TA
Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies
description Osama AA Ahmed,1,2 Khalid M El-Say,1,3 Bader M Aljaeid,1 Shaimaa M Badr-Eldin,1,4 Tarek A Ahmed1,3 1Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Minia University, Minia, Egypt; 3Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt; 4Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt Background: Vinpocetine (VNP), a semisynthetic natural product, is used as a vasodilator for cerebrovascular and age-related memory disorders. VNP suffers from low oral bioavailability owing to its low water solubility and extensive first-pass metabolism. This work aimed at utilizing D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) and alpha lipoic acid (ALA) to develop efficient micellar system for transdermal delivery of VNP. Materials and methods: VNP-TPGS-ALA micelles were prepared, characterized for particle size using particle size analyzer, and investigated for structure using transmission electron microscope. Optimization of VNP-TPGS-ALA micelles-loaded transdermal films was performed using Box–Behnken experimental design. The investigated factors were percentage of ALA in TPGS (X1), citral concentration (X2), and propylene glycol concentration (X3). Elongation percent (Y1), initial permeation after 2 hours (Y2), and cumulative permeation after 24 hours (Y3) were studied as responses. Results: Statistical analysis revealed optimum levels of 16.62%, 3%, and 2.18% for X1, X2, and X3, respectively. Fluorescent laser microscopic visualization of skin penetration of the optimized transdermal film revealed marked widespread fluorescence intensity in skin tissue after 0.5, 2, and 4 hours compared with raw VNP transdermal film formulation, which indicated enhancement of VNP skin penetration. Conclusion: The obtained results highlighted the potentiality of VNP nanostructure-based films for controlling the transdermal permeation of the drug and improving its effectiveness. Keywords: bioavailability, box behnken design, citral, fluorescent laser microscope, nanostructured-based films, permeation
format article
author Ahmed OAA
El-Say KM
Aljaeid BM
Badr-Eldin SM
Ahmed TA
author_facet Ahmed OAA
El-Say KM
Aljaeid BM
Badr-Eldin SM
Ahmed TA
author_sort Ahmed OAA
title Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies
title_short Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies
title_full Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies
title_fullStr Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies
title_full_unstemmed Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies
title_sort optimized vinpocetine-loaded vitamin e d-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/927ac8e92e704923aadabbfecaf394fa
work_keys_str_mv AT ahmedoaa optimizedvinpocetineloadedvitaminedalphatocopherolpolyethyleneglycol1000succinatealphalipoicacidmicellesasapotentialtransdermaldrugdeliverysysteminvitroandexvivostudies
AT elsaykm optimizedvinpocetineloadedvitaminedalphatocopherolpolyethyleneglycol1000succinatealphalipoicacidmicellesasapotentialtransdermaldrugdeliverysysteminvitroandexvivostudies
AT aljaeidbm optimizedvinpocetineloadedvitaminedalphatocopherolpolyethyleneglycol1000succinatealphalipoicacidmicellesasapotentialtransdermaldrugdeliverysysteminvitroandexvivostudies
AT badreldinsm optimizedvinpocetineloadedvitaminedalphatocopherolpolyethyleneglycol1000succinatealphalipoicacidmicellesasapotentialtransdermaldrugdeliverysysteminvitroandexvivostudies
AT ahmedta optimizedvinpocetineloadedvitaminedalphatocopherolpolyethyleneglycol1000succinatealphalipoicacidmicellesasapotentialtransdermaldrugdeliverysysteminvitroandexvivostudies
_version_ 1718399414977953792